Amendment: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
Release Date: February 25, 2011
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human
Development (NICHD)
The purpose of this Notice is to amend and clarify wording in Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21), PAS-10-148.
Located under Section I. Funding Opportunity Description, 1. Research Objectives, Section: Research Objectives and Scope, third bulleted list:
Research areas NOT appropriate for this FOA include studies of:
This replaces:
Research areas appropriate for this FOA include studies of:
All other aspects of this FOA remains unchanged.
Please
direct all inquiries to:
David R. Johnson, Ph.D.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases
Room 6714-B, MSC-6601
6610 Rockledge Drive
Bethesda, MD 20892-6601
Telephone: (301) 496-7104
Fax: (301) 480-1899
Email: [email protected]